Alex Sklan

Lancet Laboratories

Papers

1

Total Citations

15

H-Index

1

About

Alex Sklan is a researcher focused on the complexities of head and neck oncology, with a particular emphasis on the nuanced balance between treatment efficacy and patient quality of life. His most-cited work, "Treating head and neck cancer: for better or for worse?" (2017), has garnered 15 citations, reflecting its critical examination of the trade-offs inherent in aggressive cancer therapies. Sklan’s contributions lie in highlighting how advances in treatment—such as surgery, radiation, and chemotherapy—must be weighed against long-term functional and psychosocial outcomes, a perspective that has informed clinical decision-making and patient counseling. While his citation count is modest, the paper’s thematic depth underscores its relevance in a field where survivorship and morbidity are increasingly prioritized. Sklan’s work serves as a thoughtful reminder that progress in oncology is not solely measured by survival rates, but by the holistic well-being of patients navigating a challenging diagnosis.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Treating head and neck cancer: for better or for worse?
15 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 1
🏛 Institutions: Lancet Laboratories

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago